Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Neoplasms 2 Urinary Bladder Neoplasms 1 Strabismus 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Pain 1 Ovarian Neoplasms 1 Obesity 1 Multiple Myeloma 1 Mucositis 1 Lung Neoplasms 1 Insulin Resistance 1 Infertility, Female 1 Infertility 1 Hyperphagia 1 Hyperglycemia 1 Febrile Neutropenia 1 Emergence Delirium 1

Interventions

Meropenem 6 Ceftazidime 5 Vancomycin 4 Ciprofloxacin 3 Cefepime 3 Teicoplanin 2 Levofloxacin 2 Amikacin 2 ceftolozane, tazobactam drug combination 1 Vaccination 1 Tazobactam 1 Simvastatin 1 Pneumococcal Vaccines 1 Piperacillin, Tazobactam Drug Combination 1 Piperacillin 1 Ofloxacin 1 Micafungin 1 Metronidazole 1 Injections 1 Filgrastim 1 Cilastatin, Imipenem Drug Combination 1 Anti-Bacterial Agents 1 Amoxicillin-Potassium Clavulanate Combination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Febrile Neutropenia × Injections × Clear all

NCT04948463 2026-03-20

ELSA-FN

Murdoch Childrens Research Institute

Phase 4 Completed

Classical hematology

Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡